Lupin receives USFDA approval for Fluocinonide Topical Solution

Lupin Ltd has received final USFDA approval to market a generic version of County Line Pharmaceuticals, LLC’s Fluocinonide Topical Solution. The solution is used to relieve skin conditions like inflammation or itching that respond to the corticosteroid class of steroids. According to industry estimates, Fluocinonide topical solution USP, 0.05% clocked sales of $32.4 million in the US.

Company Profile : Lupin Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*